Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | polyketide synthase Pks9 | 0.0331 | 0.2228 | 0.2981 |
Mycobacterium ulcerans | multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0532 | 0.4752 | 0.6357 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks5 | 0.0485 | 0.4168 | 0.5576 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0532 | 0.4752 | 0.6357 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks1 | 0.036 | 0.2588 | 0.3461 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.05 | 0.4361 | 0.5834 |
Mycobacterium ulcerans | thioesterase | 0.0417 | 0.3311 | 0.443 |
Brugia malayi | serine/threonine-protein kinase 6 | 0.0905 | 0.9446 | 0.9446 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks8 | 0.0409 | 0.3214 | 0.4299 |
Echinococcus multilocularis | aurora kinase A | 0.0905 | 0.9446 | 0.5 |
Brugia malayi | AMP-binding enzyme family protein | 0.0468 | 0.3948 | 0.3948 |
Mycobacterium tuberculosis | Polyketide synthase Pks13 | 0.0748 | 0.7476 | 1 |
Loa Loa (eye worm) | fatty acid synthase | 0.0494 | 0.4277 | 0.391 |
Trichomonas vaginalis | AGC family protein kinase | 0.0905 | 0.9446 | 0.5 |
Schistosoma mansoni | protein kinase | 0.0905 | 0.9446 | 0.5 |
Mycobacterium tuberculosis | Probable thioesterase TesA | 0.0417 | 0.3311 | 0.443 |
Mycobacterium leprae | Probable polyketide synthase Pks1 | 0.0532 | 0.4752 | 0.6337 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSA | 0.05 | 0.4361 | 0.581 |
Trichomonas vaginalis | AGC family protein kinase | 0.0905 | 0.9446 | 0.5 |
Giardia lamblia | Aurora kinase | 0.0905 | 0.9446 | 0.5 |
Mycobacterium tuberculosis | Polyketide synthetase MbtC (polyketide synthase) | 0.0172 | 0.0229 | 0.0306 |
Mycobacterium leprae | PROBABLE THIOESTERASE TESA | 0.0417 | 0.3311 | 0.4398 |
Entamoeba histolytica | protein kinase, putative | 0.0905 | 0.9446 | 0.5 |
Entamoeba histolytica | serine/threonine protein kinase 6, putative | 0.0905 | 0.9446 | 0.5 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSE | 0.0331 | 0.2228 | 0.2941 |
Mycobacterium ulcerans | polyketide synthase | 0.0532 | 0.4752 | 0.6357 |
Mycobacterium ulcerans | thioesterase TesA | 0.0417 | 0.3311 | 0.443 |
Loa Loa (eye worm) | AUR protein kinase | 0.0905 | 0.9446 | 1 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSC | 0.0532 | 0.4752 | 0.6337 |
Mycobacterium tuberculosis | Probable membrane bound polyketide synthase Pks6 | 0.0748 | 0.7476 | 1 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks7 | 0.0532 | 0.4752 | 0.6357 |
Mycobacterium tuberculosis | Polyketide synthase Pks12 | 0.0532 | 0.4752 | 0.6357 |
Onchocerca volvulus | 0.0871 | 0.9025 | 0.9285 | |
Entamoeba histolytica | serine/threonine- protein kinase 6, putative | 0.0905 | 0.9446 | 0.5 |
Plasmodium falciparum | serine/threonine protein kinase, putative | 0.0905 | 0.9446 | 0.5 |
Brugia malayi | Beta-ketoacyl synthase, N-terminal domain containing protein | 0.05 | 0.4361 | 0.4361 |
Entamoeba histolytica | protein kinase, putative | 0.0905 | 0.9446 | 0.5 |
Toxoplasma gondii | beta-ketoacyl synthase, N-terminal domain-containing protein | 0.0325 | 0.2149 | 0.1101 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0905 | 0.9446 | 0.5 |
Onchocerca volvulus | Fatty acid synthase homolog | 0.0902 | 0.9416 | 1 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.05 | 0.4361 | 0.5834 |
Loa Loa (eye worm) | AUR protein kinase | 0.0905 | 0.9446 | 1 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0356 | 0.2547 | 0.1586 |
Echinococcus granulosus | serine:threonine protein kinase 12 B | 0.0905 | 0.9446 | 0.5 |
Echinococcus granulosus | aurora kinase A | 0.0905 | 0.9446 | 0.5 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.05 | 0.4361 | 0.5834 |
Toxoplasma gondii | aurora kinase | 0.0905 | 0.9446 | 1 |
Mycobacterium tuberculosis | Polyketide synthase Pks2 | 0.0485 | 0.4168 | 0.5576 |
Trichomonas vaginalis | AGC family protein kinase | 0.0905 | 0.9446 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.028 | 0.1592 | 0.0745 |
Trypanosoma brucei | aurora B kinase | 0.0905 | 0.9446 | 0.5 |
Entamoeba histolytica | protein kinase , putative | 0.0905 | 0.9446 | 0.5 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSD | 0.05 | 0.4361 | 0.581 |
Mycobacterium ulcerans | polyketide synthase | 0.05 | 0.4361 | 0.5834 |
Mycobacterium tuberculosis | Probable fatty acid synthase Fas (fatty acid synthetase) | 0.0157 | 0.0042 | 0.0056 |
Loa Loa (eye worm) | hypothetical protein | 0.0841 | 0.8643 | 0.9054 |
Loa Loa (eye worm) | AUR protein kinase | 0.0905 | 0.9446 | 1 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.05 | 0.4361 | 0.5834 |
Mycobacterium tuberculosis | Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) | 0.0468 | 0.3948 | 0.528 |
Mycobacterium tuberculosis | Probable multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0532 | 0.4752 | 0.6357 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.05 | 0.4361 | 0.5834 |
Echinococcus multilocularis | serine:threonine protein kinase 12 B | 0.0905 | 0.9446 | 0.5 |
Mycobacterium ulcerans | polyketide synthase Pks13 | 0.0748 | 0.7476 | 1 |
Plasmodium vivax | serine/threonine protein kinase 6, putative | 0.0905 | 0.9446 | 0.5 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSB | 0.0403 | 0.3131 | 0.4155 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsB | 0.0403 | 0.3131 | 0.4188 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.05 | 0.4361 | 0.5834 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks15 | 0.0202 | 0.061 | 0.0817 |
Loa Loa (eye worm) | AMP-binding enzyme family protein | 0.0468 | 0.3948 | 0.3521 |
Brugia malayi | serine/threonine kinase 12 | 0.0905 | 0.9446 | 0.9446 |
Mycobacterium leprae | Polyketide synthase Pks13 | 0.0748 | 0.7476 | 1 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.05 | 0.4361 | 0.5834 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0905 | 0.9446 | 0.5 |
Mycobacterium leprae | Probable multifunctional mycocerosic acid synthase membrane associated enzyme Mas | 0.0532 | 0.4752 | 0.6337 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsE | 0.0331 | 0.2228 | 0.2981 |
Brugia malayi | serine/threonine protein kinase 6 | 0.0905 | 0.9446 | 0.9446 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks9 | 0.0285 | 0.1644 | 0.2199 |
Mycobacterium ulcerans | fatty acid synthase Fas | 0.0157 | 0.0042 | 0.0056 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0532 | 0.4752 | 0.4276 |
Trypanosoma cruzi | aurora B kinase, putative | 0.0905 | 0.9446 | 0.5 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0403 | 0.3131 | 0.4188 |
Trichomonas vaginalis | AGC family protein kinase | 0.0905 | 0.9446 | 0.5 |
Entamoeba histolytica | serine/threonine- protein kinase 6 , putative | 0.0905 | 0.9446 | 0.5 |
Leishmania major | protein kinase, putative | 0.0905 | 0.9446 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -5.874 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.805 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.801 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.653 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.545 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.409 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.35 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.331 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.168 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.112 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.046 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.847 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.